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Cancer Network (NCCN) recommend a resection of the primary 
tumor only if patients are symptomatic or have metastatic sites 
amenable to a potentially-curative resection. Although the ratio-
nale for an up-front primary tumor resection is based on an at-
tempt to resolve potential complications from the primary tumor, 
such as bowel obstruction, uncontrollable bleeding, or tumor per-
foration [6, 9], the critical role of surgery for patients with incur-
able stage IV CRC is still inconclusive, especially for patients with 
stage IVB CRC. Furthermore, proper prognostic clinical parame-
ters, such as age, performance status, pathological grading, or lo-
calization of the primary tumor, should be considered before un-
dertaking surgery in elderly patients with stage IV CRC. Although 
very limited evidence is available with respect to the survival ben-
efit of a primary tumor resection in patients with stage IV CRC, 
recent studies demonstrated a 31% reduction in mortality with 
surgical resection of the primary tumor and an increase in sur-
vival in elderly patients with stage IV CRC [10, 11]. Consistent 
with previous studies, our retrospective study showed that pa-
tients who underwent a primary tumor resection followed by 
chemotherapy had a significantly longer survival time than pa-
tients who received first-line chemotherapy (17.2 vs. 13.6 months, 
P = 0.002) [12]. On the basis of the current limited results, a pri-
mary tumor resection is potentially associated with survival bene-
fits in elderly patients with stage IV CRC. However, primary-tu-
mor-related complications are a major concern. The rates of com-
plication in patients with an unresected primary tumor have been 
reported to range from 11.0% to 30% [2, 13, 14]. 
This study analyzed retrospectively the survival outcomes and 
the prognostic factors in elderly patients with stage IVB CRC. The 
current study showed that the patients in the resection group had 
significantly longer median survival times compared to the pa-
tients in the nonresection group (12.43 months vs. 3.58 months, P 
< 0.001). In addition, male gender, higher level of carcinoembry-
onic antigen, higher aspartate aminotransferase level, and nonre-
section of the primary tumor were independent poor prognostic 
factors on the multivariate analysis. However, the relatively short 
follow-up time and the small sample size are major drawbacks to 
interpreting the survival benefits and the prognostic factors 
Colorectal cancer (CRC) is one of the most common malignant 
tumors that lead to cancer-related death worldwide, and it has an 
increasing incidence rate. Approximately 20% to 30% of patients 
with CRC are found to have distant metastases at the time of di-
agnosis [1]. To date, with recent advances in systemic chemother-
apy, nonoperative treatment has become the mainstay of treat-
ment in patients with incurable metastatic CRC [2, 3]. Given the 
progress in chemotherapy regimens and palliative techniques 
such as endoluminal stenting and given the high mortality of can-
cer-directed surgery, the prognostic impact of a primary tumor 
resection in patients with stage IV CRC has been under debate [4-
6]. A previous analysis of Surveillance Epidemiology and End Re-
sults (SEER)-Medicare-linked data between 1991 and 1999 re-
ported a 72% cancer-directed surgery rate in elderly patients (age 
≥ 65) with stage IV CRC [6]. However, more recent SEER-Medi-
care data from 2001 to 2007 demonstrated a statistically signifi-
cant decrease in the rate of surgical resections of primary tumors 
from 64.6% in 2001 to 57.1% in 2007 [7]. Similarly, The Nether-
lands’ Cancer Registry also found a significant decrease in pri-
mary tumor resection rates from 66% to 56% and an increase in 
systemic chemotherapy from 2.0% in 1989–1993 to 40% in 2004–
2006 in elderly patients with stage IV CRC disease [8]. These 
treatment trends may indicate that practitioners are rapidly 
adopting the use of modern combination chemotherapy and that 
a paradigm shift in the treatment of stage IV CRC is beginning. 
Current practice guidelines from the National Comprehensive 
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clearly [15]. A large-scale, randomized study is needed to clearly 
establish the true benefits primary tumor resection for stage IVB 
CRC. In conclusion, the appropriate role of a surgical resection 
for treating stage IVB CRC, including its prognostic impact on 
tumor-related symptom control, its survival benefits and its im-
pact on quality of life, remains to be fully evaluated.
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